Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM.
about
Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.
@en
Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.
@nl
type
label
Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.
@en
Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.
@nl
prefLabel
Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.
@en
Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.
@nl
P2093
P2860
P50
P1476
Epithelial-to-Mesenchymal Tran ...... Lung Cancer by Suppressing BIM
@en
P2093
Aaron N Hata
Angel Garcia
Anthony C Faber
Brad E Windle
Bradley Bernstein
Daniel A R Heisey
Elizabeth L Lockerman
Haichuan Hu
Hannah L Archibald
Hidenori Kitai
P2860
P304
P356
10.1158/1078-0432.CCR-17-1577
P407
P577
2017-10-19T00:00:00Z